Cargando…
A survey on the application of oral propranolol and atenolol for the management of infantile hemangiomas in mainland China: Survey on propranolol atenolol hemangiomas
Since 2008, oral propranolol has evolved as the first-line therapy for infantile hemangiomas (IHs). Meanwhile, oral atenolol gradually shows comparative effectiveness versus oral propranolol with few side effects. Here, we conducted a mobile internal survey among a group of Chinese clinicians about...
Autores principales: | Zhao, Ze-Liang, Liu, Chao, Wang, Qi-Zhang, Zhang, Wen-Bo, Shao, Lu, Wu, Hai-Wei, Zheng, Jia-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793351/ https://www.ncbi.nlm.nih.gov/pubmed/33429792 http://dx.doi.org/10.1097/MD.0000000000024146 |
Ejemplares similares
-
Propranolol or atenolol for the management of infantile hemangioma: Implications for long-term health
por: Hermans, Mireille M., et al.
Publicado: (2023) -
Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma
por: Seebauer, Caroline T., et al.
Publicado: (2022) -
Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma
por: Hermans, Mireille M., et al.
Publicado: (2022) -
Oral Atenolol versus Propranolol in the Treatment of Infantile Hemangioma: A Systematic Review and Meta-Analysis
por: Pattanshetti, Swapnil Annasaheb, et al.
Publicado: (2022) -
Correction to: Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma
por: Hermans, Mireille M., et al.
Publicado: (2023)